Status: current, Defined. Date: 31-May 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3326001000168110 | Restamine (doxylamine succinate 25 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3326011000168113 | Restamine 25 mg tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Restamine 25 mg tablet | Is a | Restamine | true | Inferred relationship | Some | ||
| Restamine 25 mg tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Restamine 25 mg tablet | Is a | doxylamine succinate 25 mg tablet | true | Inferred relationship | Some | ||
| Restamine 25 mg tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Restamine 25 mg tablet | has unit of use | tablet | true | Inferred relationship | Some | 1754666323 | |
| Restamine 25 mg tablet | has Australian BoSS | doxylamine succinate | true | Inferred relationship | Some | 1754666322 | |
| Restamine 25 mg tablet | has intended active ingredient | doxylamine | true | Inferred relationship | Some | 1754666322 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Restamine 25 mg tablet, 20, blister pack | has TPUU | True | Restamine 25 mg tablet | Inferred relationship | Some | 1 |
| Restamine 25 mg tablet, 20 | has TPUU | True | Restamine 25 mg tablet | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR